Page last updated: 2024-10-22

amlodipine and Hyperlipoproteinemia Type II

amlodipine has been researched along with Hyperlipoproteinemia Type II in 2 studies

Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.

Hyperlipoproteinemia Type II: A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins).

Research Excerpts

ExcerptRelevanceReference
"Amlodipine inhibited AngII-induced aortic aneurysms in both the abdominal and ascending regions, and atherosclerosis in hypercholesterolemic mice."7.79Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice. ( Balakrishnan, A; Cassis, LA; Charnigo, R; Chen, X; Daugherty, A; Howatt, DA; Moorleghen, JJ; Morris, AJ; Rateri, DL, 2013)
"Amlodipine inhibited AngII-induced aortic aneurysms in both the abdominal and ascending regions, and atherosclerosis in hypercholesterolemic mice."3.79Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice. ( Balakrishnan, A; Cassis, LA; Charnigo, R; Chen, X; Daugherty, A; Howatt, DA; Moorleghen, JJ; Morris, AJ; Rateri, DL, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamamoto, H1
Takada, T1
Yamanashi, Y1
Ogura, M1
Masuo, Y1
Harada-Shiba, M1
Suzuki, H1
Chen, X1
Rateri, DL1
Howatt, DA1
Balakrishnan, A1
Moorleghen, JJ1
Morris, AJ1
Charnigo, R1
Cassis, LA1
Daugherty, A1

Other Studies

2 other studies available for amlodipine and Hyperlipoproteinemia Type II

ArticleYear
VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body.
    Scientific reports, 2017, 04-04, Volume: 7, Issue:1

    Topics: Amlodipine; Animals; Biological Transport; Cholesterol; Drug Carriers; Hyperlipoproteinemia Type II;

2017
Amlodipine reduces AngII-induced aortic aneurysms and atherosclerosis in hypercholesterolemic mice.
    PloS one, 2013, Volume: 8, Issue:11

    Topics: Amlodipine; Angiotensin II; Animals; Aortic Aneurysm; Atherosclerosis; Hyperlipoproteinemia Type II;

2013